Shafer Christina bought NGNE
May 5, 2026 · Form 4 insider transaction
Shafer Christina bought 120,000 shares of Neurogene Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
120,000
Price
$0.00
Total value
N/A
InsiderShafer Christina
RoleOfficer
CompanyNeurogene Inc. (NGNE)
SecurityNon-Qualified Stock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateMay 5, 2026
Filing dateMay 7, 2026
Shares owned after120,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This option represents the right to purchase 120,000 shares of the Issuer's common stock, one quarter of which will vest on April 20, 2027 with the remaining three quarters vesting on the 20th of each month in equal monthly installments through April 20, 2030, subject to the Reporting Person's continued provision of service to the Issuer on each vesting date.